Terms: = Liver cancer AND CD274, PDL1, 29126, ENSG00000120217, PDCD1L1, PD-L1, MGC142296, PDCD1LG1, MGC142294, B7H1, Q9NZQ7, B7-H AND Staging
10 results:
1. A Case of Curative Treatment with Apatinib and Camrelizumab Following liver Resection for Advanced Hepatocellular Carcinoma.
Huang J; Liang R; Lu C; Lu L; Li S; Tang M; Huang X; Huang S; Mai R; Gao X; Li S; Zeng C; Lin Y; Ye J
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686291
[TBL] [Abstract] [Full Text] [Related]
2. Esophageal cancer - French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNIcancer, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR).
Veziant J; Bouché O; Aparicio T; Barret M; El Hajbi F; Lepilliez V; Lesueur P; Maingon P; Pannier D; Quero L; Raoul JL; Renaud F; Seitz JF; Serre AA; Vaillant E; Vermersch M; Voron T; Tougeron D; Piessen G; ; ; ; ; ; ; ; ; ;
Dig Liver Dis; 2023 Dec; 55(12):1583-1601. PubMed ID: 37635055
[TBL] [Abstract] [Full Text] [Related]
3. Nucleoporin 107 is a prognostic biomarker in hepatocellular carcinoma associated with immune infiltration.
Nong JS; Zhou X; Liu JQ; Luo JZ; Huang JM; Xie HX; Yang KJ; Wang J; Ye XP; Peng T
Cancer Med; 2023 May; 12(9):10990-11009. PubMed ID: 36952458
[TBL] [Abstract] [Full Text] [Related]
4. Metastatic malignant melanoma of the breast: report of a case and review of the literature.
Mastoraki A; Gkiala A; Theodoroleas G; Mouchtouri E; Strimpakos A; Papagiannopoulou D; Schizas D
Folia Med (Plovdiv); 2022 Apr; 64(2):354-358. PubMed ID: 35851793
[TBL] [Abstract] [Full Text] [Related]
5. Integrating Machine Learning and Tumor Immune Signature to Predict Oncologic Outcomes in Resected Biliary Tract cancer.
Ji GW; Wang K; Xia YX; Wang JS; Wang XH; Li XC
Ann Surg Oncol; 2021 Jul; 28(7):4018-4029. PubMed ID: 33230745
[TBL] [Abstract] [Full Text] [Related]
6. Prediction of overall survival in resectable intrahepatic cholangiocarcinoma: IS
Tian M; Liu W; Tao C; Tang Z; Zhou Y; Song S; Jin L; Wang H; Jiang X; Zhou P; Fang Y; Qu W; Ding Z; Peng Y; Fu X; Qiu S; Zhou J; Fan J; Shi Y
Cancer Sci; 2020 Apr; 111(4):1084-1092. PubMed ID: 31971309
[TBL] [Abstract] [Full Text] [Related]
7. Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer.
Landi L; D'Incà F; Gelibter A; Chiari R; Grossi F; Delmonte A; Passaro A; Signorelli D; Gelsomino F; Galetta D; Giannarelli D; Soto Parra H; Minuti G; Tiseo M; Migliorino MR; Cognetti F; Toschi L; Bidoli P; Piantedosi F; Calabro' L; Cappuzzo F
J Immunother Cancer; 2019 Nov; 7(1):316. PubMed ID: 31752994
[TBL] [Abstract] [Full Text] [Related]
8. Expression of Programmed Death Ligand 1 Is Associated with the Prognosis of Intrahepatic Cholangiocarcinoma.
Dong Z; Liao B; Shen W; Sui C; Yang J
Dig Dis Sci; 2020 Feb; 65(2):480-488. PubMed ID: 31410753
[TBL] [Abstract] [Full Text] [Related]
9. CCRK is a novel signalling hub exploitable in cancer immunotherapy.
Mok MT; Zhou J; Tang W; Zeng X; Oliver AW; Ward SE; Cheng AS
Pharmacol Ther; 2018 Jun; 186():138-151. PubMed ID: 29360538
[TBL] [Abstract] [Full Text] [Related]
10. Upregulation of circulating pd-l1/PD-1 is associated with poor post-cryoablation prognosis in patients with HBV-related hepatocellular carcinoma.
Zeng Z; Shi F; Zhou L; Zhang MN; Chen Y; Chang XJ; Lu YY; Bai WL; Qu JH; Wang CP; Wang H; Lou M; Wang FS; Lv JY; Yang YP
PLoS One; 2011; 6(9):e23621. PubMed ID: 21912640
[TBL] [Abstract] [Full Text] [Related]
